Biopharmaceutical companies are committed to enhancing public health through responsible sharing of clinical trial data in a manner that is consistent with the following Principles:

• Safeguarding the privacy of patients
• Respecting the integrity of national regulatory systems
• Maintaining incentives for investment in biomedical research